María Eugenia Sarasquete

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia

Cristina Jiménez, Elena Sebastián, Carmen Chillón et al. · Leukemia · 2013 · 264 citations

Myd88 L265p, Disease Mechanism, Genetic Disorder +6

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis

María Eugenia Sarasquete, Ramón García‐Sánz, Miguel Alcoceba et al. · Blood · 2008 · 235 citations · Full text

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling

Norma C. Gutiérrez, María Eugenia Sarasquete, Irena Misiewicz-Krzemińska et al. · Leukemia · 2010 · 210 citations

Microrna Expression, Genetics, Immunology +10

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

María Eugenia Sarasquete, Ramón García‐Sánz, David González et al. · PubMed · 2005 · 184 citations

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

Noemí Puig, María Eugenia Sarasquete, Ana Balanzategui et al. · Leukemia · 2013 · 168 citations

Hematological Malignancy, Oncology, Medicine +11